Curadis Overview

  • Founded
  • 2008
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Curadis General Information

Description

Developer of therapeutic drugs intended to focus on the treatment of cancer. The company's drugs are engaged in developing of novel drugs and therapeutic concepts for the treatment of hormone-dependent diseases and cancers, enabling patients to recover from various critical diseases.

Contact Information

Website
www.curadis.eu
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Henkestraße 91
  • 91052 Erlangen
  • Germany
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Curadis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Jun-2019 Completed Out of Business
3. Later Stage VC 01-Jul-2016 Completed Generating Revenue
2. Early Stage VC 08-Dec-2010 Completed Generating Revenue
1. Seed Round 01-Jan-2008 Completed Generating Revenue
To view Curadis’s complete valuation and funding history, request access »

Curadis Board Members (2)

Name Representing Role Since
Stefan Beil Ph.D Sobera Capital Board Member 000 0000
You’re viewing 1 of 2 board members. Get the full list »